Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.

Maertens JA, Girmenia C, Brüggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN) .

J Antimicrob Chemother. 2018 Dec 1;73(12):3221-3230. doi: 10.1093/jac/dky286.

PMID:
30085172
2.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

3.

Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units.

Shahin J, Allen EJ, Patel K, Muskett H, Harvey SE, Edgeworth J, Kibbler CC, Barnes RA, Biswas S, Soni N, Rowan KM, Harrison DA; FIRE Study Investigators.

BMC Infect Dis. 2016 Sep 9;16:480. doi: 10.1186/s12879-016-1803-9.

4.

Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit.

Theocharidou E, Agarwal B, Jeffrey G, Jalan R, Harrison D, Burroughs AK, Kibbler CC.

Clin Microbiol Infect. 2016 Feb;22(2):189.e1-189.e7. doi: 10.1016/j.cmi.2015.10.020. Epub 2015 Nov 10.

5.

Improved Standardization of the Bio-Rad Platelia Aspergillus Galactomannan Antigen Sandwich Enzyme Immunoassay Using the DS2 (Dynex) Enzyme-Linked Immunosorbent Assay (ELISA) Processing System.

Gorton RL, White PL, Bagkeris E, Cotterall D, Desai R, McHugh T, Kibbler CC.

J Clin Microbiol. 2015 Jul;53(7):2072-8. doi: 10.1128/JCM.00157-15. Epub 2015 Apr 15.

6.

British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases.

Schelenz S, Barnes RA, Barton RC, Cleverley JR, Lucas SB, Kibbler CC, Denning DW; British Society for Medical Mycology.

Lancet Infect Dis. 2015 Apr;15(4):461-74. doi: 10.1016/S1473-3099(15)70006-X. Epub 2015 Mar 12. Review.

PMID:
25771341
7.

A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients.

Ceesay MM, Desai SR, Berry L, Cleverley J, Kibbler CC, Pomplun S, Nicholson AG, Douiri A, Wade J, Smith M, Mufti GJ, Pagliuca A.

Br J Haematol. 2015 Jan;168(2):219-29. doi: 10.1111/bjh.13114. Epub 2014 Sep 1.

PMID:
25179933
8.

Comparative analysis of Gram's stain, PNA-FISH and Sepsityper with MALDI-TOF MS for the identification of yeast direct from positive blood cultures.

Gorton RL, Ramnarain P, Barker K, Stone N, Rattenbury S, McHugh TD, Kibbler CC.

Mycoses. 2014 Oct;57(10):592-601. doi: 10.1111/myc.12205. Epub 2014 May 26.

PMID:
24862948
9.

Evaluation of a short, on-plate formic acid extraction method for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based identification of clinically relevant yeast isolates.

Gorton RL, Seaton S, Ramnarain P, McHugh TD, Kibbler CC.

J Clin Microbiol. 2014 Apr;52(4):1253-5. doi: 10.1128/JCM.03489-13. Epub 2014 Jan 29.

10.

Candida nivariensis isolated from a renal transplant patient with persistent candiduria-Molecular identification using ITS PCR and MALDI-TOF.

Gorton RL, Jones GL, Kibbler CC, Collier S.

Med Mycol Case Rep. 2013 Oct 25;2:156-8. doi: 10.1016/j.mmcr.2013.10.001. eCollection 2013 Oct 25.

11.

Infections in patients taking Rituximab for hematologic malignancies: two-year cohort study.

Lanini S, Molloy AC, Prentice AG, Ippolito G, Kibbler CC.

BMC Infect Dis. 2013 Jul 12;13:317. doi: 10.1186/1471-2334-13-317.

12.

Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact.

Stone NR, Gorton RL, Barker K, Ramnarain P, Kibbler CC.

J Clin Microbiol. 2013 Apr;51(4):1301-2. doi: 10.1128/JCM.00028-13. Epub 2013 Feb 6.

13.

From the patient to the clinical mycology laboratory: how can we optimise microscopy and culture methods for mould identification?

Vyzantiadis TA, Johnson EM, Kibbler CC.

J Clin Pathol. 2012 Jun;65(6):475-83. doi: 10.1136/jclinpath-2011-200500. Epub 2012 Feb 3. Review.

PMID:
22308268
14.

Detection and identification of bacteria in clinical samples by 16S rRNA gene sequencing: comparison of two different approaches in clinical practice.

Jenkins C, Ling CL, Ciesielczuk HL, Lockwood J, Hopkins S, McHugh TD, Gillespie SH, Kibbler CC.

J Med Microbiol. 2012 Apr;61(Pt 4):483-8. doi: 10.1099/jmm.0.030387-0. Epub 2011 Dec 8.

PMID:
22160310
15.

European expert opinion on the management of invasive candidiasis in adults.

Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, Cuenca-Estrella M, Herbrecht R, Jacobs F, Kalin M, Kibbler CC, Lortholary O, Martino P, Meis JF, Muñoz P, Odds FC, De Pauw BE, Rex JH, Roilides E, Rogers TR, Ruhnke M, Ullmann AJ, Uzun Ö, Vandewoude K, Vincent JL, Donnelly JP.

Clin Microbiol Infect. 2011 Sep;17 Suppl 5:1-12. doi: 10.1111/j.1469-0691.2011.03615.x.

16.

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.

Marks DI, Pagliuca A, Kibbler CC, Glasmacher A, Heussel CP, Kantecki M, Miller PJ, Ribaud P, Schlamm HT, Solano C, Cook G; IMPROVIT Study Group.

Br J Haematol. 2011 Nov;155(3):318-27. doi: 10.1111/j.1365-2141.2011.08838.x. Epub 2011 Aug 22.

17.

Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis.

Lanini S, Molloy AC, Fine PE, Prentice AG, Ippolito G, Kibbler CC.

BMC Med. 2011 Apr 12;9:36. doi: 10.1186/1741-7015-9-36. Review.

18.

Melanin externalization in Candida albicans depends on cell wall chitin structures.

Walker CA, Gómez BL, Mora-Montes HM, Mackenzie KS, Munro CA, Brown AJ, Gow NA, Kibbler CC, Odds FC.

Eukaryot Cell. 2010 Sep;9(9):1329-42. doi: 10.1128/EC.00051-10. Epub 2010 Jun 11.

19.

Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit.

Schelenz S, Barnes RA, Kibbler CC, Jones BL, Denning DW.

J Infect. 2009 Feb;58(2):145-53. doi: 10.1016/j.jinf.2008.12.006. Epub 2009 Jan 29.

PMID:
19185349
20.

Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?

Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, Guarro J, Haase G, Kibbler CC, Meyer W, O'Donnell K, Petti CA, Rodriguez-Tudela JL, Sutton D, Velegraki A, Wickes BL.

J Clin Microbiol. 2009 Apr;47(4):877-84. doi: 10.1128/JCM.01685-08. Epub 2008 Dec 10. Review. No abstract available.

21.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.

22.

Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series.

Fowler S, Webber A, Cooper BS, Phimister A, Price K, Carter Y, Kibbler CC, Simpson AJ, Stone SP.

J Antimicrob Chemother. 2007 May;59(5):990-5. Epub 2007 Mar 26.

PMID:
17387117
23.

The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.

Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S, Brown EM, Wiffen PJ, Davey PG.

J Antimicrob Chemother. 2007 May;59(5):833-40. Epub 2007 Mar 26. Review.

PMID:
17387116
24.

The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.

Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S, Brown EM, Wiffen PJ, Davey PG.

Lancet Infect Dis. 2007 Apr;7(4):282-8. Review.

PMID:
17376385
25.

Pathogen 'shift' in febrile neutropenia.

Kibbler CC, Prentice HG.

Curr Opin Infect Dis. 1999 Aug;12(4):351-4. No abstract available.

PMID:
17035798
26.

A reappraisal of current approaches to the management of fungal infections in neutropenic patients.

Kibbler CC, Prentice HG.

Curr Opin Infect Dis. 1998 Aug;11(4):397-400. No abstract available.

PMID:
17033401
27.

Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing.

Odds FC, Davidson AD, Jacobsen MD, Tavanti A, Whyte JA, Kibbler CC, Ellis DH, Maiden MC, Shaw DJ, Gow NA.

J Clin Microbiol. 2006 Oct;44(10):3647-58.

28.

A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections.

White PL, Barton R, Guiver M, Linton CJ, Wilson S, Smith M, Gomez BL, Carr MJ, Kimmitt PT, Seaton S, Rajakumar K, Holyoake T, Kibbler CC, Johnson E, Hobson RP, Jones B, Barnes RA.

J Mol Diagn. 2006 Jul;8(3):376-84.

29.

Validation and clinical application of molecular methods for the identification of molds in tissue.

Paterson PJ, Seaton S, McHugh TD, McLaughlin J, Potter M, Prentice HG, Kibbler CC.

Clin Infect Dis. 2006 Jan 1;42(1):51-6. Epub 2005 Nov 29.

PMID:
16323091
30.

Molecular confirmation of invasive infection caused by Chaetomium globosum.

Paterson PJ, Seaton S, Yeghen T, McHugh TD, McLaughlin J, Hoffbrand AV, Kibbler CC.

J Clin Pathol. 2005 Mar;58(3):334. No abstract available.

31.

Predictive value of isolating Pseudomonas aeruginosa from aerobic and anaerobic blood culture bottles.

Enoch DA, Simpson AJ, Kibbler CC.

J Med Microbiol. 2004 Nov;53(Pt 11):1151-4.

PMID:
15496395
32.

Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.

Bigley VH, Duarte RF, Gosling RD, Kibbler CC, Seaton S, Potter M.

Bone Marrow Transplant. 2004 Nov;34(9):815-7.

PMID:
15361915
33.

Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature.

Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S.

BMJ. 2004 Sep 4;329(7465):533. Review.

34.

The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes: implications for treatment, screening and surveillance in the UK.

Maudsley J, Stone SP, Kibbler CC, Iliffe SR, Conaty SJ, Cookson BD, Duckworth GJ, Johnson A, Wallace PG.

J Hosp Infect. 2004 Jul;57(3):258-62.

PMID:
15236857
35.

Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes.

Cooper BS, Medley GF, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Duckworth G, Lai R, Ebrahim S.

Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10223-8. Epub 2004 Jun 25.

36.

Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.

Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Canton E, Zimmermann K, Seaton S, Grillot R; ECMM Working Group on Candidaemia.

Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):317-22. Epub 2004 Mar 17.

PMID:
15029512
37.
38.

Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling.

Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth GJ, Lai R, Ebrahim S.

Health Technol Assess. 2003;7(39):1-194. Review.

39.

Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.

Paterson PJ, Seaton S, Prentice HG, Kibbler CC.

J Antimicrob Chemother. 2003 Nov;52(5):873-6. Epub 2003 Sep 30.

PMID:
14519673
40.

Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit.

Cepeda J, Hayman S, Whitehouse T, Kibbler CC, Livermore D, Singer M, Wilson AP.

J Antimicrob Chemother. 2003 Sep;52(3):533-4. Epub 2003 Jul 29. No abstract available.

PMID:
12888581
41.

Management and outcome of bloodstream infections due to Candida species in England and Wales.

Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA.

J Hosp Infect. 2003 May;54(1):18-24.

PMID:
12767842
42.

British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.

Denning DW, Kibbler CC, Barnes RA; British Society for Medical Mycology.

Lancet Infect Dis. 2003 Apr;3(4):230-40. Review.

PMID:
12679266
44.

Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature.

Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC.

Bone Marrow Transplant. 2002 Apr;29(8):691-8. Review.

45.

Endoscopic decontamination: an audit and practical review.

Ruddy M, Kibbler CC.

J Hosp Infect. 2002 Apr;50(4):261-8. Review.

PMID:
12014898
46.

What is the risk of transfusing micro-organisms during stem cell transplantation?

Kibbler CC, Prentice HG.

Curr Opin Infect Dis. 2000 Aug;13(4):333-335. No abstract available.

PMID:
11964798
47.

Lactobacillus endocarditis caused by a probiotic organism.

Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM.

Clin Microbiol Infect. 1999 May;5(5):290-292. No abstract available.

48.

Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection.

Elsaghier AA, Aucken HM, Hamilton-Miller JM, Shaw S, Kibbler CC.

J Antimicrob Chemother. 2002 Feb;49(2):423-4. No abstract available.

PMID:
11815594
49.

Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.

Prentice HG, Hann IM, Nazareth B, Paterson P, Bhamra A, Kibbler CC.

Br J Haematol. 2001 Oct;115(1):46-52. Erratum in: Br J Haematol 2002 Jun;117(4):1002.

PMID:
11722408
50.

Controlling infection in British nursing homes. It is time for a national strategy.

Stone SP, Kibbler CC, Bowman C, Stott D.

BMJ. 2001 Mar 3;322(7285):506. No abstract available.

Supplemental Content

Loading ...
Support Center